carbenoxolone sodium has been researched along with kn 62 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberto, AP; Dahl, G; Iglesias, R; Locovei, S; Roque, A; Scemes, E; Spray, DC | 1 |
| Iglesias, RM; Spray, DC | 1 |
2 other study(ies) available for carbenoxolone sodium and kn 62
| Article | Year |
|---|---|
P2X7 receptor-Pannexin1 complex: pharmacology and signaling.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Carbenoxolone; Cell Line; Cell Membrane Permeability; Connexins; Dose-Response Relationship, Drug; Flufenamic Acid; Gap Junctions; Humans; Macrophages; Mefloquine; Membrane Potentials; Mice; Nerve Tissue Proteins; Oocytes; Phosphorylation; Receptors, Purinergic P2; Receptors, Purinergic P2X7; RNA Interference; RNA, Small Interfering; Signal Transduction; src-Family Kinases; Xenopus | 2008 |
Pannexin1-mediated ATP release provides signal transmission between Neuro2A cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Apyrase; Carbenoxolone; Cell Communication; Cell Line, Tumor; Connexins; Gap Junctions; Humans; Membrane Potentials; Mice; Nerve Tissue Proteins; Neuroblastoma; Patch-Clamp Techniques; Purinergic P2X Receptor Antagonists; Signal Transduction; Suramin | 2012 |